http://www.fda.gov/cder/dmpq/freshair.htmRead More

/docs/ICH-CDER-API-GMPguide.pdfRead More

/Docs/FDA-DeviceLabelingandManualsGuidance.pdfRead More

http://www.fda.gov/cdrh/comp/guidance/2619.pdfRead More

http://www.fda.gov/cdrh/ode/guidance/1326.pdfRead More

The final Device Center Inspection Compliance Policy Guide (provided at the link above and in the Library on this site) Part VI, Page 11, lists the following as points of contact related to software: “i. Questions regarding compliance of product software, stand alone software, process equipment software or the Year: 2000 Problem: Stewart Crumpler Office...Read More

Last fall John Taylor, Director, FDA Office of Enforcement took over as leader of the agency’s Part 11 Compliance Committee. As of January 2001: 1. The draft guidances on Validation and Glossary of Terms are now in formal review at the agency. This does not mean they are close to final. 2. FDA has suspended...Read More

In 2000, a coalition of trade associations was formed to provide input to FDA regarding interpretation of Part 11. This unusual effort across industries has been undertaken due to the global nature of the rule and the cost and impact of compliance to the rule depending on interpretation. The initial group of six national trade...Read More

/docs/Tissue-celldoc.pdfRead More

Earlier this month FDA recognized UL 1998 for software. It followed up in the second half of the month by publishing new supplmentary information sheets for all recognized software standards that explains the recognition and how each could be used to reduce software documentation in submissions. Subscribers to SoftwareCPR.com can login, go to the Library...Read More

As of 11/15/00 FDA CDRH formally recognizes “ANSI/UL 1998 Software in Programmable Components” for software submissions. Details of the recognition have not yet been posted by FDA as of 11/19/00 but the original intent was for this to be the first software standard to be recognized for devices with software of a MAJOR level of...Read More

The Good Automated Manufacturing Practice (GAMP) organization issued a final draft for review of a guidance for achieving Part 11 compliance for Electronic Records;Electronic Signatures. It is available at the link provided or go to www.gamp.org for more information.. GAMP Part11 draft Note: this is not an FDA Guidance. It was written by an industry...Read More

http://www.fda.gov/cdrh/ode/guidance/1167.htmlRead More

The link above provides the slides and notes of a presentation made by David Manalan reqarding FDA’s Quality System Inspection Technique. David is an associate of SoftwareCPR and you can reach him at DManalan@softwarecpr.com or 978-266-1220. BOSCON manalan QSITRead More

http://www.fda.gov/cdrh/ode/guidance/997.pdfRead More

http://www.fda.gov/cdrh/ode/guidance/583.pdfRead More

/docs/ElectronicNDAprocessing.pdfRead More

/docs/ASQBiomedicalDivisionPart11comments.PDFRead More

At a half-day breakout session on the AAMI Medical Device Software Standard, the HIMA Conformance Assessment Tool, UL 1998, the FDA Off-the-shelf software guidance, and other software standards and policy initiatives for the medical device industry was presented as part of the annual AAMI International Standards Conference. FDA and several industry speakers participated. John Murray,...Read More

/docs/PDAtechreport32.PDFRead More

The Device Quality System Regulation (GMP) explicitly requires signatures in the following places: The sections of the regulation which specifically require signatures are: · Sec. 820.30 Design controls.c & d · Sec. 820.40 Document controls a & b · Sec. 820.75 Process validation a · Sec. 820.80 Receiving, in-process, and finished device acceptance d&e. ·...Read More

/docs/510kNitricoxidedevices.PDfRead More

/Docs/BBexmatchFDAreviewChecklist.pdfRead More

/Docs/calaqstn.pdfRead More

Status of FDA permission requirements for Blood Bank establishment use of electronic crossmatch as of November 18, 1999: Because 21 CFR 606.151 requires a serologic crossmatch those hospitals (all hospitals) who wish to use the electronic crossmatch must apply for a variance to 21 CFR 606.151 (as allowed by 21 CFR 640.120) to gain written...Read More

/Docs/ISBT128Nov99.pdfRead More

/docs/Part11videotape1099.PDFRead More

/docs/otssswsubmissionguidance.pdfRead More

http://www.fda.gov/cdrh/ode/126.htmlRead More

/docs/Linweldpart11wl.PDFRead More

/docs/QSITGUIDE1999.pdfRead More

/docs/GPSVcrumplerpresentation.PDFRead More

/docs/FDAFDLIOverviewSWonlyslides699.pdfRead More

http://www.fda.gov/cdrh/ode/2246.htmlRead More

/Docs/FDApresentationonPart11ANDClinicalTrialsSW.pdfRead More

/Docs/ORAPart11CPG.pdfRead More

http://www.fda.gov/cdrh/ode/2242.pdfRead More

/docs/LIMSclassificationCFR862-2100.pdfRead More

/Docs/faq011299motisepresentation.pdfRead More

http://www.fda.gov/cdrh/ode/100.htmlRead More

http://www.fda.gov/cdrh/ode/radcalibrators.pdfRead More

/docs/FDA-MRIguidance1998.pdfRead More

http://www.fda.gov/cdrh/ode/93.htmlRead More

/docs/510kQandA.pdfRead More

/Docs/FDAfoodcomputersystemguide.pdfRead More

http://www.fda.gov/cdrh/ode/powerpump.pdfRead More

/docs/PACsclassificationRevision.pdfRead More

FDA CDRH Office of Device Evaluation standards recognition statement for ” IEC 60601-1-4:1996, Medical electrical equipment – Part 1: General requirements For safety; 4. Collateral Standard: Programmable electrical medical systems”. FDA did not choose to recognize this standard for software submissions or even outright for risk management. They did issue a recognition statement explaining their...Read More

/docs/HEMODIALYSISDELIVERYSYSTEMS.pdfRead More

/docs/washerdisinfectors1998draft.pdfRead More